HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Yao Selected Research

Hypoxia (Hypoxemia)

5/2022Two-photon responsive porphyrinic metal-organic framework involving Fenton-like reaction for enhanced photodynamic and sonodynamic therapy.
6/2021Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
7/2016The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.
4/2014Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Yao Research Topics

Disease

62Neoplasms (Cancer)
09/2022 - 04/2006
18Asthma (Bronchial Asthma)
10/2021 - 11/2004
16Inflammation (Inflammations)
06/2021 - 09/2005
12Neoplasm Metastasis (Metastasis)
05/2022 - 10/2010
12Infections
03/2021 - 03/2008
12Renal Cell Carcinoma (Grawitz Tumor)
10/2016 - 01/2007
10Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 01/2013
10Chronic Hepatitis B
08/2021 - 10/2005
6Hepatocellular Carcinoma (Hepatoma)
05/2022 - 12/2015
6Lung Neoplasms (Lung Cancer)
09/2017 - 12/2013
5Fibrosis (Cirrhosis)
10/2021 - 05/2009
5Portal Hypertension
10/2021 - 11/2013
5Hepatitis B
08/2021 - 02/2007
4Hypoxia (Hypoxemia)
05/2022 - 04/2014
4Hemorrhage
10/2021 - 10/2007
4Airway Remodeling
10/2021 - 09/2006
4Melanoma (Melanoma, Malignant)
02/2019 - 06/2013
4Glioma (Gliomas)
01/2019 - 01/2016
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2013
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 04/2014
3Breast Neoplasms (Breast Cancer)
01/2020 - 05/2011
3Carcinogenesis
07/2014 - 01/2004
2Pain (Aches)
10/2022 - 12/2020
2Malaria
06/2022 - 11/2021
2Carcinoma (Carcinomatosis)
01/2022 - 01/2021
2Hepatic Encephalopathy
08/2021 - 11/2013
2Liver Failure
06/2021 - 12/2014
2COVID-19
06/2021 - 01/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2021 - 05/2005
2Respiratory Hypersensitivity
01/2021 - 05/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 12/2013
2Papillary Thyroid Cancer
07/2018 - 11/2017
2Ischemia
02/2018 - 10/2017
2Massive Hepatic Necrosis
02/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2007
16Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2009
12Pharmaceutical PreparationsIBA
11/2021 - 11/2012
12VaccinesIBA
01/2021 - 09/2009
11Biological ProductsIBA
09/2022 - 03/2013
9AntigensIBA
10/2017 - 04/2006
6Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2013 - 02/2007
5SolutionsIBA
09/2022 - 01/2014
5Small Interfering RNA (siRNA)IBA
12/2015 - 12/2013
4Cadherins (E-Cadherin)IBA
05/2022 - 12/2014
4Antiviral Agents (Antivirals)IBA
08/2021 - 03/2008
4Interleukin-13IBA
01/2021 - 03/2010
4RNA (Ribonucleic Acid)IBA
01/2021 - 12/2015
4CytokinesIBA
01/2021 - 01/2012
4PolymersIBA
01/2020 - 01/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 01/2004
4Indicators and Reagents (Reagents)IBA
01/2015 - 01/2007
3Long Noncoding RNAIBA
01/2022 - 08/2014
3EnzymesIBA
12/2021 - 02/2012
3Histones (Histone)IBA
02/2021 - 12/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 05/2009
3LipopolysaccharidesIBA
01/2020 - 01/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 08/2007
3Therapeutic UsesIBA
02/2018 - 02/2007
3Hepatitis B e AntigensIBA
01/2018 - 02/2007
3Co-Repressor ProteinsIBA
09/2017 - 01/2014
3Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 07/2016
3Liposomes (Liposome)IBA
07/2016 - 01/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 01/2012
3Peptides (Polypeptides)IBA
01/2016 - 06/2013
3Messenger RNA (mRNA)IBA
12/2015 - 04/2006
3SteroidsIBA
04/2014 - 10/2007
3aluminum sulfate (alum)IBA
01/2013 - 02/2007
2Oxygen (Dioxygen)IBA
05/2022 - 06/2021
2CateninsIBA
05/2022 - 11/2020
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
2ImmunosorbentsIBA
12/2021 - 02/2012
2Cisplatin (Platino)FDA LinkGeneric
12/2021 - 08/2007
2SaltsIBA
11/2021 - 01/2019
2Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 05/2016
2tocilizumab (atlizumab)FDA Link
06/2021 - 02/2014
2ChitosanIBA
01/2021 - 04/2013
2MacrolidesIBA
01/2021 - 01/2019
2ChemokinesIBA
01/2021 - 01/2020
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2020 - 05/2009
2Lactic Acid (Lactate)FDA LinkGeneric
10/2019 - 01/2019
2N-propionylprocainamideIBA
01/2019 - 07/2016
2Oxidoreductases (Dehydrogenase)IBA
01/2019 - 06/2013
2punicalaginIBA
07/2018 - 11/2017
2GalactosamineIBA
02/2018 - 01/2017
2LipidsIBA
11/2017 - 11/2012
2Ginkgo biloba extract (Rokan)IBA
10/2017 - 01/2015
2HLA-DPB1 antigen (HLA DPB1)IBA
10/2017 - 01/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2017 - 01/2016
2OzoneIBA
06/2017 - 12/2015
2LigandsIBA
07/2016 - 01/2016

Therapy/Procedure

31Therapeutics
10/2022 - 02/2012
8Immunotherapy
01/2022 - 09/2012
5Transjugular Intrahepatic Portasystemic Shunt
10/2021 - 11/2013
4Surgical Portasystemic Shunt (Portosystemic Shunt)
10/2021 - 11/2013
4Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2021 - 04/2014
3Stents
03/2021 - 11/2013
3Drug Therapy (Chemotherapy)
02/2014 - 03/2008
3Nephrectomy
11/2013 - 10/2010
2Castration
01/2022 - 11/2013
2Aftercare (After-Treatment)
01/2016 - 03/2014